H.R. 5364
116th Congress
House
End Price Gouging for Insulin Act
Official title: To require the Secretary of Health and Human Services to establish an annual reference price for insulin products for purposes of Federal health programs, and for other purposes.
Health
AsiaAustraliaCanadaDepartment of Health and Human Services
More subjectsShow fewer subjects
EuropeExecutive agency funding and structureFranceGermanyHealth care costs and insuranceHealth programs administration and fundingIndian social and development programsInflation and pricesItalyJapanMedicaidMedical researchMedicareNetherlandsNorth AmericaPrescription drugsResearch administration and fundingResearch and developmentRetail and wholesale tradesSpainSwedenSwitzerlandUnited KingdomVeterans' medical care
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 14, 2020
Referred to the Subcommittee on Health.
Dec 18, 2019
Referred to the Subcommittee for Indigenous Peoples of the United States.
Dec 10, 2019
Referred to the Subcommittee on Health.
Dec 9, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, Veterans' Affairs, Oversight and Reform, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 9, 2019
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Referred to the Subcommittee on Health.
Plain-English summary
End Price Gouging for Insulin Act
This bill requires the Department of Health and Human Services to set a maximum price for insulin products for individuals and enrollees of federal health programs.
Related & companion bills
1
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Cosponsors
22
D
Blunt Rochester, Lisa
Butterfield, G. K.
D
Clarke, Yvette D.
D
Clyburn, James E.
Fudge, Marcia
D
Johnson, Henry C. "Hank"
JOHNSON, EDDIE
D
Kelly, Robin L.
Lawrence, Brenda
Lee, Barbara
Richmond, Cedric
D
Waters, Maxine
D
Watson Coleman, Bonnie
D
Wilson, Frederica S.
D
Bishop, Sanford D.
Brown, Anthony
CLAY, WM.
Lipinski, Daniel
McEachin, A.
D
Norton, Eleanor Holmes
Payne, Donald
D
Thompson, Bennie G.
Cite this page
U.S. Congress. (2026). H.R. 5364: End Price Gouging for Insulin Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-5364/
"H.R. 5364: End Price Gouging for Insulin Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-5364/.
H.R. 5364, 116th Cong. (2026), https://openamerica.io/bill/116-HR-5364/.
[H.R. 5364: End Price Gouging for Insulin Act](https://openamerica.io/bill/116-HR-5364/)